Alpha 2.0
Login Register
» Articles » PMID: 39775199

Performance of LDBio Aspergillus ICT IgM/IgG Lateral Flow Assay in Diagnosing Chronic Pulmonary Aspergillosis in Community Versus Hospital Setting

Overview
Journal Mycopathologia
Specialties Microbiology
Pharmacology
Date 2025 Jan 8
PMID 39775199
Authors
Inderpaul Singh Sehgal
Kathirvel Soundappan
Valliappan Muthu
Sahajal Dhooria
Kuruswamy Thurai Prasad
Shivaprakash M Rudramurthy
Ashutosh Nath Aggarwal
Rajesh Raju
Mandeep Garg
Nidhi Prabhakar
Arunaloke Chakrabarti
Ritesh Agarwal
Affiliations
Soon will be listed here.
Abstract

Background: LDBio immunochromatographic lateral flow assay, a point-of care test, detects IgM/IgG antibodies against Aspergillus fumigatus (LDBio-ALFA). LDBio-ALFA has been evaluated for diagnosing chronic pulmonary aspergillosis (CPA) in hospital patients, though its efficacy in field settings remains unexamined.

Objective: Our primary objective was to assess the diagnostic accuracy of LDBio-ALFA in diagnosing CPA in a field and a hospital cohort. The secondary objective was to compare the diagnostic performance of LDBio-ALFA and A. fumigatus-IgG measured by a commercial automated fluorescent enzyme immunoassay (FEIA) using latent class analysis (LCA).

Methods: We prospectively enrolled adult subjects with post-tuberculosis lung abnormality (PTLA) from a tertiary care hospital (hospital cohort), and designated microscopy centers and a community health center (field cohort). We measured A. fumigatus-IgG using LDBio-ALFA and FEIA in the same serum sample.

Results: We enrolled 508 subjects, of which 122 and 386 constituted field and hospital cohorts. CPA was diagnosed in 325/508 (64%) subjects. The CPA prevalence was higher in the hospital (78% [301/386]) than in the field cohort (19.7% [24/122]). The sensitivity and specificity of LDBio-ALFA in the entire cohort in diagnosing CPA was 81.2% and 85.3%. The sensitivity of LDBio-ALFA in the field cohort was 83.3% and 81.1% in the hospital population. On LCA, the sensitivity and specificity of the FEIA method (A. fumigatus-IgG ≥ 27 mgA/L) was 100% and 86.7%, while for LDBio-ALFA it was for 84.5% and 81.3% for diagnosing CPA.

Conclusion: LDBio-ALFA is a valuable test for diagnosing CPA in the field and in hospital patients. However, a negative test should be confirmed using an automated immunoassay.

References
1.
Sehgal I, Dhooria S, Muthu V, Prasad K, Agarwal R . An overview of the available treatments for chronic cavitary pulmonary aspergillosis. Expert Rev Respir Med. 2020; 14(7):715-727. DOI: 10.1080/17476348.2020.1750956. View
2.
Denning D, Cole D, Ray A . New estimation of the prevalence of chronic pulmonary aspergillosis (CPA) related to pulmonary TB - a revised burden for India. IJID Reg. 2022; 6:7-14. PMC: 9772841. DOI: 10.1016/j.ijregi.2022.11.005. View
3.
Sehgal I, Dhooria S, Prasad K, Muthu V, Aggarwal A, Agarwal R . Comparative diagnostic accuracy of immunoprecipitation versus immunoassay methods for detecting Aspergillus fumigatus-specific IgG in allergic bronchopulmonary aspergillosis: A systematic review and meta-analysis. Mycoses. 2022; 65(9):866-876. DOI: 10.1111/myc.13488. View
4.
Sehgal I, Dhooria S, Soundappan K, Rudramurthy S, Chakrabarti A, Agarwal R . Comparison of three sample types for performing LDBio Aspergillus immunochromatographic technology lateral flow assay for IgG/IgM antibody detection in chronic aspergillosis. Clin Microbiol Infect. 2022; 29(3):404-405. DOI: 10.1016/j.cmi.2022.11.031. View
5.
Singh S, Choudhary H, Agnihotri S, Sehgal I, Agarwal R, Kaur H . LDBio Aspergillus immunochromatographic test lateral flow assay for IgG/IgM antibody detection in chronic pulmonary aspergillosis: Single-centre evaluation and meta-analysis. Indian J Med Microbiol. 2022; 40(2):204-210. DOI: 10.1016/j.ijmmb.2022.03.002. View